Trial Profile
An Observational study on the treatment patterns, discontinuations and dose titration of Pregabalin in patients with Neuropathic pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 22 May 2017 New trial record